Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDZ domain-containing protein 4 (PDZD4) is a scaffold protein predominantly located at the cell cortex, below the plasma membrane. It is expressed at restricted levels during normal fetal brain development, but its expression is aberrantly increased in some cancers, particularly synovial sarcoma, where it promotes cell proliferation. While its broader physiological role is incompletely defined, PDZD4 belongs to a family of proteins featuring PDZ domains, enabling it to mediate specific protein–protein interactions in cellular signaling complexes. Some paralogs in this protein family possess E3 ubiquitin ligase activity, suggesting involvement in ubiquitin-mediated proteostasis, but this function in PDZD4 remains speculative. Current data support its possible role as a biomarker or therapeutic target in synovial sarcoma and a candidate gene in autism spectrum disorder and periarthritis; however, it is not the focus of any approved pharmacologic interventions to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ domain-containing protein 4 (PDZD4).